Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Mar 18;6:285. doi: 10.1038/s42003-023-04670-z

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2023, corrected publication 2024

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

Fig. 5 — a Expression of miR-3085-5p in healthy control (n = 40) and cirrhotic patients (n = 40). b miR-3085-5p expression in primary HSCs at day 1, 2 and 4 (n = 3 per group). c miR-3085-5p expression in isolated HSCs from CCl₄ mice (n = 6 per group). d MIAT expression in primary HSCs with miR-3085-5p mimics or inhibitor treatment (n = 3 per group). e miR-3085-5p expression in primary HSCs transfected with Ad-shMIAT or Ad-MIAT (n = 3 per group). f Cell proliferation in HSCs transfected with Ad-shCtrl, Ad-shMIAT or Ad-shMIAT plus miR-3085-5p inhibitor (n = 3 per group). Scale bar, 50 μm. g Protein expressions of Type I collagen and α-SMA in HSCs transfected with Ad-shCtrl, Ad-shMIAT or Ad-shMIAT plus miR-3085-5p inhibitor (n = 3 per group). h Protein expressions of Type I collagen and α-SMA in HSCs transfected with Ad-Ctrl, Ad-MIAT or Ad-MIAT plus miR-3085-5p mimics (n = 3 per group). Each value is the mean ± SD of three independent experiments. *p < 0.05.